• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

典型的慢性淋巴细胞白血病 B 细胞受体识别基质细胞上促进生存的抗原。

Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells.

机构信息

Department of Oncology and Hematology, Hubertus Wald Tumorzentrum/University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

PLoS One. 2010 Dec 30;5(12):e15992. doi: 10.1371/journal.pone.0015992.

DOI:10.1371/journal.pone.0015992
PMID:21209908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3012720/
Abstract

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. Survival of CLL cells depends on their close contact with stromal cells in lymphatic tissues, bone marrow and blood. This microenvironmental regulation of CLL cell survival involves the stromal secretion of chemo- and cytokines as well as the expression of adhesion molecules. Since CLL survival may also be driven by antigenic stimulation through the B-cell antigen receptor (BCR), we explored the hypothesis that these processes may be linked to each other. We tested if stromal cells could serve as an antigen reservoir for CLL cells, thus promoting CLL cell survival by stimulation through the BCR. As a proof of principle, we found that two CLL BCRs with a common stereotyped heavy chain complementarity-determining region 3 (previously characterized as "subset 1") recognize antigens highly expressed in stromal cells--vimentin and calreticulin. Both antigens are well-documented targets of autoantibodies in autoimmune disorders. We demonstrated that vimentin is displayed on the surface of viable stromal cells and that it is present and bound by the stereotyped CLL BCR in CLL-stroma co-culture supernatant. Blocking the vimentin antigen by recombinant soluble CLL BCR under CLL-stromal cell co-culture conditions reduces stroma-mediated anti-apoptotic effects by 20-45%. We therefore conclude that CLL BCR stimulation by stroma-derived antigens can contribute to the protective effect that the stroma exerts on CLL cells. This finding sheds a new light on the understanding of the pathobiology of this so far mostly incurable disease.

摘要

慢性淋巴细胞白血病(CLL)是西方世界最常见的白血病。CLL 细胞的存活依赖于它们与淋巴组织、骨髓和血液中的基质细胞的紧密接触。这种 CLL 细胞存活的微环境调节涉及基质细胞分泌的趋化因子和细胞因子以及粘附分子的表达。由于 CLL 的存活也可能通过 B 细胞抗原受体(BCR)的抗原刺激驱动,我们探索了这样一种假设,即这些过程可能相互关联。我们测试了基质细胞是否可以作为 CLL 细胞的抗原库,从而通过 BCR 的刺激促进 CLL 细胞的存活。作为原理验证,我们发现两个具有共同刻板重链互补决定区 3(先前被表征为“亚组 1”)的 CLL BCR 识别高度表达在基质细胞中的抗原——波形蛋白和钙网蛋白。这两种抗原都是自身免疫性疾病中自身抗体的公认靶标。我们证明了波形蛋白在存活的基质细胞表面表达,并且在 CLL-基质共培养上清液中存在并被刻板的 CLL BCR 结合。在 CLL-基质细胞共培养条件下,用重组可溶性 CLL BCR 阻断波形蛋白抗原可使基质介导的抗凋亡作用降低 20-45%。因此,我们得出结论,基质衍生抗原对 CLL BCR 的刺激可以有助于基质对 CLL 细胞发挥的保护作用。这一发现为理解这种迄今为止基本上无法治愈的疾病的病理生物学提供了新的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ea/3012720/67cc872368e0/pone.0015992.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ea/3012720/d9b929f5513d/pone.0015992.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ea/3012720/5de35700665d/pone.0015992.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ea/3012720/ce971825a458/pone.0015992.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ea/3012720/734bd0d39515/pone.0015992.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ea/3012720/67cc872368e0/pone.0015992.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ea/3012720/d9b929f5513d/pone.0015992.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ea/3012720/5de35700665d/pone.0015992.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ea/3012720/ce971825a458/pone.0015992.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ea/3012720/734bd0d39515/pone.0015992.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/05ea/3012720/67cc872368e0/pone.0015992.g005.jpg

相似文献

1
Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells.典型的慢性淋巴细胞白血病 B 细胞受体识别基质细胞上促进生存的抗原。
PLoS One. 2010 Dec 30;5(12):e15992. doi: 10.1371/journal.pone.0015992.
2
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling.慢性淋巴细胞白血病是由抗原非依赖性细胞自主信号驱动的。
Nature. 2012 Sep 13;489(7415):309-12. doi: 10.1038/nature11309.
3
The DNx Mouse Model of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recapitulates the Biased IGHV Gene Usage, Stereotypy, and Antigen-Specific HCDR3 Selection of Its Human Counterpart.DNx 小鼠慢性淋巴细胞白血病/小淋巴细胞淋巴瘤模型重现了其人类对应物的 IGHV 基因使用偏倚、同型性、以及抗原特异性 HCDR3 选择。
Front Immunol. 2021 Apr 12;12:627602. doi: 10.3389/fimmu.2021.627602. eCollection 2021.
4
Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.通过B细胞受体的持续信号传导诱导Mcl-1并促进慢性淋巴细胞白血病B细胞的存活。
Blood. 2005 Jun 15;105(12):4820-7. doi: 10.1182/blood-2004-07-2669. Epub 2005 Feb 22.
5
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者亚群中存在显著相似的抗原受体。
J Clin Invest. 2004 Apr;113(7):1008-16. doi: 10.1172/JCI19399.
6
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.脾酪氨酸激酶抑制可预防慢性淋巴细胞白血病中趋化因子和整合素介导的基质保护作用。
Blood. 2010 Jun 3;115(22):4497-506. doi: 10.1182/blood-2009-07-233692. Epub 2010 Mar 24.
7
B cell receptor and antigens in CLL.慢性淋巴细胞白血病中的 B 细胞受体和抗原。
Adv Exp Med Biol. 2013;792:1-24. doi: 10.1007/978-1-4614-8051-8_1.
8
Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.未突变和突变的慢性淋巴细胞白血病源自自身反应性B细胞前体,尽管它们表达不同的抗体反应性。
J Clin Invest. 2005 Jun;115(6):1636-43. doi: 10.1172/JCI24387. Epub 2005 May 2.
9
Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.使用Syk抑制剂TAK-659抑制BCR信号传导可防止慢性淋巴细胞白血病细胞中的基质介导信号传导。
Oncotarget. 2017 Jan 3;8(1):742-756. doi: 10.18632/oncotarget.13557.
10
Exploiting B-cell Receptor Stereotypy to Design Tailored Immunotherapy in Chronic Lymphocytic Leukemia.利用 B 细胞受体的特异性来设计慢性淋巴细胞白血病的个体化免疫治疗。
Clin Cancer Res. 2021 Feb 1;27(3):729-739. doi: 10.1158/1078-0432.CCR-20-1632. Epub 2020 Oct 13.

引用本文的文献

1
Conventional and non-conventional antigen-binding sites promote the development and function of chronic lymphocytic leukemia stereotyped subset #4 clones.传统和非传统抗原结合位点促进慢性淋巴细胞白血病定型亚群#4克隆的发育和功能。
Front Immunol. 2025 Aug 21;16:1607189. doi: 10.3389/fimmu.2025.1607189. eCollection 2025.
2
The Role of Tumor Microenvironment and Targeted Therapy in Chronic Lymphocytic Leukemia.肿瘤微环境与靶向治疗在慢性淋巴细胞白血病中的作用
Curr Issues Mol Biol. 2025 Aug 1;47(8):604. doi: 10.3390/cimb47080604.
3
Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse-like cells via an RNA-dependent mechanism.

本文引用的文献

1
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.脾酪氨酸激酶抑制可预防慢性淋巴细胞白血病中趋化因子和整合素介导的基质保护作用。
Blood. 2010 Jun 3;115(22):4497-506. doi: 10.1182/blood-2009-07-233692. Epub 2010 Mar 24.
2
Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.多种骨髓基质细胞可保护慢性淋巴细胞白血病细胞免受自发凋亡和药物诱导的凋亡:建立一个可靠且可重复的系统来评估基质细胞黏附介导的耐药性。
Blood. 2009 Nov 12;114(20):4441-50. doi: 10.1182/blood-2009-07-233718. Epub 2009 Sep 17.
3
慢性淋巴细胞白血病细胞来源的细胞外囊泡通过RNA依赖机制诱导单核细胞分化为类滋养细胞,从而促进白血病的侵袭性。
Hemasphere. 2025 Jan 16;9(1):e70068. doi: 10.1002/hem3.70068. eCollection 2025 Jan.
4
JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLL.JNK1 抑制剂靶向远端 B 细胞受体信号转导,并克服 CLL 中 BTK 抑制剂耐药性。
J Exp Med. 2025 Jan 6;222(1). doi: 10.1084/jem.20230681. Epub 2024 Nov 21.
5
B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection.在慢性 HCV 感染患者中,表达与病毒中和相关的突变 IGHV1-69 编码抗原受体的 B 细胞表现出类似淋巴瘤的转录组。
Hepatol Commun. 2024 Jul 31;8(8). doi: 10.1097/HC9.0000000000000503. eCollection 2024 Aug 1.
6
Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia.间充质干细胞在白血病中的生物学特性与治疗特性
Int J Mol Sci. 2024 Feb 21;25(5):2527. doi: 10.3390/ijms25052527.
7
Chronic Lymphocytic Leukemia: Disease Biology.慢性淋巴细胞白血病:疾病生物学。
Acta Haematol. 2024;147(1):8-21. doi: 10.1159/000533610. Epub 2023 Sep 16.
8
NF-kB and the CLL microenvironment.核因子-κB与慢性淋巴细胞白血病微环境
Front Oncol. 2023 Mar 30;13:1169397. doi: 10.3389/fonc.2023.1169397. eCollection 2023.
9
Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation.具有高转化风险的结节性淋巴细胞为主型霍奇金淋巴瘤的进化克隆轨迹。
Haematologica. 2021 Oct 1;106(10):2654-2666. doi: 10.3324/haematol.2021.278427.
10
Role of Specific B-Cell Receptor Antigens in Lymphomagenesis.特定B细胞受体抗原在淋巴瘤发生中的作用。
Front Oncol. 2020 Dec 9;10:604685. doi: 10.3389/fonc.2020.604685. eCollection 2020.
The microenvironment in mature B-cell malignancies: a target for new treatment strategies.
成熟B细胞恶性肿瘤中的微环境:新治疗策略的靶点
Blood. 2009 Oct 15;114(16):3367-75. doi: 10.1182/blood-2009-06-225326. Epub 2009 Jul 27.
4
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.B细胞抗原受体信号传导增强慢性淋巴细胞白血病细胞的迁移和存活:用新型脾酪氨酸激酶抑制剂R406进行特异性靶向治疗。
Blood. 2009 Jul 30;114(5):1029-37. doi: 10.1182/blood-2009-03-212837. Epub 2009 Jun 2.
5
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.CD38/CD31、CCL3和CCL4趋化因子以及CD49d/血管细胞黏附分子-1通过维持慢性淋巴细胞白血病细胞存活的一系列连续事件相互关联。
Cancer Res. 2009 May 1;69(9):4001-9. doi: 10.1158/0008-5472.CAN-08-4173. Epub 2009 Apr 21.
6
Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach.亚型选择性磷酸肌醇3'-激酶抑制剂抑制CXCR4信号传导并克服慢性淋巴细胞白血病中基质细胞介导的耐药性:一种新的治疗方法。
Blood. 2009 May 28;113(22):5549-57. doi: 10.1182/blood-2008-06-165068. Epub 2009 Mar 24.
7
High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.慢性淋巴细胞白血病B细胞在类滋养细胞共培养中以及BCR刺激后对T细胞趋化因子CCL3和CCL4的高水平表达。
Blood. 2009 Mar 26;113(13):3050-8. doi: 10.1182/blood-2008-07-170415. Epub 2008 Dec 12.
8
AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance.AT-101可诱导慢性淋巴细胞白血病B细胞凋亡,并克服基质细胞介导的Mcl-1诱导及耐药性。
Blood. 2009 Jan 1;113(1):149-53. doi: 10.1182/blood-2008-02-138560. Epub 2008 Oct 3.
9
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.具有常见刻板重排的慢性淋巴细胞白血病抗体识别非肌肉肌球蛋白重链IIA。
Blood. 2008 Dec 15;112(13):5122-9. doi: 10.1182/blood-2008-06-162024. Epub 2008 Sep 23.
10
ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin.ERP57的膜转位通过控制钙网蛋白的膜转位决定肿瘤细胞死亡的免疫原性。
J Immunol. 2008 Aug 15;181(4):2533-43. doi: 10.4049/jimmunol.181.4.2533.